169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

• Jeffrey Miller,
• Tom Lee,
• Ryan Bjordahl,
• Frank Cichocki,
• Jianfang Ning,
• Zachary Davis,
• Katie Tuininga,
• Hongbo Wang,
• Paul Rogers,
• Moyar Ge,
• Bob Valamehr,
• Clark Chen

Affiliations

Jeffrey Miller

1University of Minnesota, Minneapolis, MN, USA

Tom Lee

1Fate Therapeutics, San Diego, CA, USA

Ryan Bjordahl

1Fate Therapeutics, San Diego, CA, USA

Frank Cichocki

1University of Minnesota, Minneapolis, MN, USA

Jianfang Ning

1University of Minnesota, Minneapolis, MN, USA

Zachary Davis

1University of Minnesota, Minneapolis, MN, USA

Katie Tuininga

1University of Minnesota, Minneapolis, MN, USA

Hongbo Wang

1University of Minnesota, Minneapolis, MN, USA

Paul Rogers

2Fate Therapeutics, Inc., San Diego, CA, USA

Moyar Ge

2Fate Therapeutics, Inc., San Diego, CA, USA

Bob Valamehr

2Fate Therapeutics, Inc., San Diego, CA, USA

Clark Chen

2Fate Therapeutics, Inc., San Diego, CA, USA